Maternal and neonatal effects of different umbilical cord clamping method after delivery in Ilorin: A randomised control study.

Not Applicable

Recruiting

• Conditions: Pregnancy and Childbirth; maternal blood losss after delivery to rule out postpartum haemorrhage; Paediatrics

• Registration Number: PACTR202404884596632
• Lead Sponsor: AKERAADEGBOYEGA GANIYAT

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-01-19
• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 168

Inclusion Criteria

•A pregnant woman who consented herself and her baby to participate in the study.
•Intrapartum haemoglobin concentration =10g/dl
•Spontaneous vaginal delivery
•A live vigorous baby at birth.

Exclusion Criteria

•Umbilical cord abnormalities e.g true knots, pseudoknots.
•Rhesus negative women
•Patient with chronic medical conditions e.g Sickle cell disease, diabetes mellitus.
•Maternal infections e.g patient with hepatitis B, hepatitis C and HIV
•Antenatally diagnosed congenital anomaly or apparent at birth.
•Antepartum haemorrhage

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome will be the mean neonatal haemoglobin at 24-48hours of life and duration of third stage of labour

Secondary Outcome Measures

Name	Time	Method
eonatal secondary outcome includes APGAR scores at first and fifth minutes of life, serum bilirubin level, need for phototherapy, development of polycythaemia and need for NICU admission. The maternal secondary outcome includes estimated blood loss, primary postpartum haemorrhage, need for blood transfusion and retained placenta.